These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7848363)

  • 1. Antitumor activity of a piperidine phospholipid.
    Houlihan WJ; Lee ML; Munder PG; Handley DA; Nemecek GA; Jaeggi CS; Winslow CW
    Arzneimittelforschung; 1994 Dec; 44(12):1384-8. PubMed ID: 7848363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic oxygen analogues of alkyl-lysophospholipids. Synthesis and neoplastic cell growth inhibitory properties.
    Houlihan WJ; Lee ML; Munder PG; Winslow CM; Cheon SH; D'Aries FJ; DeLillo AK; Jaeggi CS; Mason RB; Parrino VA
    J Lipid Mediat; 1990; 2(5):295-307. PubMed ID: 2133273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of the R- and S-enantiomers of RS-2-[[hydroxy[[2-[ (octadecyloxy)methyl]tetrahydrofuran-2-yl]methoxy]-phosphinyl]oxy]-N, N,N,-trimethylethylaminium hydroxide inner salt.
    Houlihan WJ; Prasad K; Underwood R; Repic O; Munder PG
    J Med Chem; 1996 Jan; 39(2):605-8. PubMed ID: 8558533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells.
    Dive C; Watson JV; Workman P
    Cancer Res; 1991 Feb; 51(3):799-806. PubMed ID: 1988120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of SRI 62-834, a cyclic ether analog of ET-18-OCH3.
    Houlihan WJ; Lee ML; Munder PG; Nemecek GM; Handley DA; Winslow CM; Happy J; Jaeggi C
    Lipids; 1987 Nov; 22(11):884-90. PubMed ID: 2832680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical pharmacology and possible mechanism of action of the novel antitumor agent 5-(4'-piperidinomethylphenyl)-2,3-dihydroimidazo [2,1-a]isoquinoline.
    Houlihan WJ; Munder PG; Handley DA; Nemecek GA
    Arzneimittelforschung; 1995 Oct; 45(10):1133-7. PubMed ID: 8595076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glycero-3-phosphocholine and its analogues platelet activating factor and carbamyl-platelet activating factor on the biosynthesis of interleukin-6 in human thymic epithelial cells cultivated in vitro.
    Cardile V; Mascarucci P; De Simoni MG; Jiang X; Bindoni M
    Cytokine; 1996 Sep; 8(9):698-701. PubMed ID: 8932980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor.
    Bennett SA; Birnboim HC
    Mol Carcinog; 1997 Dec; 20(4):366-75. PubMed ID: 9433481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
    Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M
    Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
    Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
    Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New tumoricidal semisynthetic ether phospholipid, plasmanyl-(N-acyl)ethanolamine (PNAE(s)) and enhancement of its tumoricidal activity by calcium ions.
    Kára J; Konovalova AL; Krasnova MA; Liebl V; Bejsovcová L
    Neoplasma; 1993; 40(4):213-7. PubMed ID: 8272147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor efficiency of novel fluoro-substituted 6-amino-2-phenylbenzothiazole hydrochloride salts in vitro and in vivo.
    Stojkovic R; Karminski-Zamola G; Racane L; Tralic-Kulenovic V; Glavas-Obrovac L; Ivankovic S; Radacic M
    Methods Find Exp Clin Pharmacol; 2006; 28(6):347-54. PubMed ID: 16894403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines.
    Shoji M; Fukuhara T; Winton EF; Berdel WE; Vogler WR
    Exp Hematol; 1994 Jan; 22(1):13-8. PubMed ID: 8282054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor ether lipids: endocytosis as a determinant of cellular sensitivity.
    Workman P
    Cancer Cells; 1991 Aug; 3(8):315-7. PubMed ID: 1657088
    [No Abstract]   [Full Text] [Related]  

  • 15. Alteration of platelet-activating factor-induced signal transduction in macrophages by n-3 fatty acids.
    Chakrabarti R; Hubbard NE; Lim D; Erickson KL
    Cell Immunol; 1997 Jan; 175(1):76-84. PubMed ID: 9015191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell kill and cytostasis by ET-18-OCH3 and heat.
    Fujiwara K; Modest EJ; Wallen CA
    Anticancer Res; 1995; 15(4):1333-8. PubMed ID: 7654017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma.
    Strassheim D; Shafer SH; Phelps SH; Williams CL
    Cancer Res; 2000 May; 60(10):2730-6. PubMed ID: 10825148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
    Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
    J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.
    Davol PA; Bizuneh A; Frackelton AR
    Anticancer Res; 1999; 19(3A):1705-13. PubMed ID: 10470104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages.
    Camussi G; Montrucchio G; Lupia E; Soldi R; Comoglio PM; Bussolino F
    J Immunol; 1997 Feb; 158(3):1302-9. PubMed ID: 9013973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.